Cipla logo

CIPLA - Cipla Share Price

₹885.2 -17.2  -1.9%

Last Trade - 13/04/21

Large Cap
Market Cap £6.93bn
Enterprise Value £6.86bn
Revenue £1.84bn
Position in Universe 59th / 3106
Unlock CIPLA Revenue
Relative Strength (%)
1m +14.6%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -5.83%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
113,454 137,901 146,302 152,193 163,624 171,320 195,044 209,653 +8.6%
-15.7 +14.4 +4.2 +25.7 -4.7 -5.6 +60.7 +7.15
Balance Sheet
FINANCIAL BRIEF: : For the nine months ended 31 December 2020, CiplaLtd revenues increased 14% to RS145.53B. Net incomeincreased 53% to RS19.91B. Revenues reflect New Venturessegment increase from RS1.45B to RS3.08B. Net incomebenefited from Other Expenditure decrease of 13% to RS31.3B(expense), Depreciation/Amortization decrease of 6% toRS7.82B (expense). Basic Earnings per Share excludingExtraordinary Items increased from RS16.13 to RS24.70.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for CIPLA
Graphical History


CIPLA Revenue Unlock CIPLA Revenue

Net Income

CIPLA Net Income Unlock CIPLA Revenue

Normalised EPS

CIPLA Normalised EPS Unlock CIPLA Revenue

PE Ratio Range

CIPLA PE Ratio Range Unlock CIPLA Revenue

Dividend Yield Range

CIPLA Dividend Yield Range Unlock CIPLA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
CIPLA EPS Forecasts Unlock CIPLA Revenue
Profile Summary

Cipla Limited is a holding company. The Company is a pharmaceutical company. The Company's strategic business units include Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company's geographical segments include India, USA, South Africa and Rest of the World. The Company manufactures metered dose inhalers, dry powder inhalers, nasal sprays, nebulizers and a range of inhaled accessory devices. Cipla Global Access is a tender-based institutional business that concentrates on approximately four therapy areas: human immunodeficiency virus/acquired immuno deficiency syndrome (HIV/AIDS), malaria, multi drug-resistant tuberculosis and reproductive health. The Company offers its products for the therapeutic areas, including cardiovascular, children's health, dermatology and cosmetology, diabetes, HIV/AIDS, infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women's health.

Last Annual March 31st, 2020
Last Interim December 31st, 2020
Incorporated August 17, 1935
Public Since November 3, 1994
No. of Shareholders: 242,917
No. of Employees: 24,034
Sector Healthcare
Industry Pharmaceuticals
Index S&P BSE 100 , Nifty 50 ,
Exchange National Stock Exchange of India
Shares in Issue 806,463,279
Free Float (0.0%)
Eligible for
CIPLA Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for CIPLA
Upcoming Events for CIPLA
Friday 14th May, 2021
Full Year 2021 Cipla Ltd Earnings Release
Thursday 5th August, 2021 Estimate
Q1 2022 Cipla Ltd Earnings Release
Friday 27th August, 2021 Estimate
Cipla Ltd Annual Shareholders Meeting
Frequently Asked Questions for Cipla
What is the Cipla share price?

As of 13/04/21, shares in Cipla are trading at ₹885.2, giving the company a market capitalisation of £6.93bn. This share price information is delayed by 15 minutes.

How has the Cipla share price performed this year?

Shares in Cipla are currently trading at ₹885.2 and the price has moved by 49.31% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Cipla price has moved by -6.1% over the past year.

What are the analyst and broker recommendations for Cipla?

Of the analysts with advisory recommendations for Cipla, there are there are currently 19 "buy" , 4 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Cipla is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Cipla next release its financial results?

Cipla is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Cipla dividend yield?

Cipla does not currently pay a dividend.

Does Cipla pay a dividend?

Cipla does not currently pay a dividend.

When does Cipla next pay dividends?

Cipla does not currently pay a dividend.

How do I buy Cipla shares?

To buy shares in Cipla you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Cipla?

Shares in Cipla are currently trading at ₹885.2, giving the company a market capitalisation of £6.93bn.

Where are Cipla shares listed? Where are Cipla shares listed?

Here are the trading details for Cipla:

Country of listing: India
Exchange: NSI
Ticker Symbol: CIPLA
What kind of share is Cipla?

Based on an overall assessment of its quality, value and momentum, Cipla is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Cipla share price forecast 2021?

Shares in Cipla are currently priced at ₹885.2. At that level they are trading at 8.81% discount to the analyst consensus target price of 0.00.

Analysts covering Cipla currently have a consensus Earnings Per Share (EPS) forecast of 31.803 for the next financial year.

How can I tell whether the Cipla share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cipla. Over the past six months, the relative strength of its shares against the market has been -6.73%. At the current price of ₹885.2, shares in Cipla are trading at 15.06% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Cipla PE Ratio?

The Cipla PE ratio based on its reported earnings over the past 12 months is 31.95. The shares are currently trading at ₹885.2.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Cipla?

Cipla's management team is headed by:

Yusuf Hamied - NEC
M. Hamied - NVC
S. Radhakrishnan - NED
Adil Zainulbhai - LED
Samina Hamied - VCH
Naina Kidwai - NID
Kedar Upadhye - CFO
Umang Vohra - CEO
Rajendra Chopra - CCO
Ranjana Pathak - OTH
Geena Malhotra - CTO
Raju Mistry - OTH
Paul Miller - CEX
Pradeep Bhadauria - CSO
Swapn Malpani - OTH
Who are the major shareholders of Cipla?

Here are the top five shareholders of Cipla based on the size of their shareholding:

Hamied (Yusuf K) Individual Investor
Percentage owned: 20.33% (164.0m shares)
Ahmed (Sophie) Individual Investor
Percentage owned: 5.7% (46.0m shares)
Hamied (Mustafa Khwaja) Individual Investor
Percentage owned: 4.29% (34.6m shares)
ICICI Prudential Asset Management Co. Ltd. Investment Advisor
Percentage owned: 3.04% (24.5m shares)
SBI Funds Management Pvt. Ltd. Investment Advisor
Percentage owned: 2.95% (23.8m shares)
Similar to CIPLA
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.